BioMarin Pharmaceutical, Inc. (BMRN)
56.19
+1.60
(+2.93%)
USD |
NASDAQ |
Jan 20, 15:35
BioMarin Pharmaceutical Market Cap: 10.79B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.417B |
| Gilead Sciences, Inc. | 154.70B |
| Merck & Co., Inc. | 271.81B |
| AbbVie, Inc. | 377.28B |
| Biogen, Inc. | 24.16B |
Market Cap Related Metrics
| PE Ratio | 21.05 |
| PS Ratio | 3.562 |
| PEG Ratio | 0.3468 |
| Price to Book Value | 1.782 |
| Price to Free Cash Flow | 13.31 |
| Price | 56.19 |
| Earnings Yield | 4.75% |
| PEGY Ratio | 0.3468 |
| Operating PE Ratio | 12.84 |
| Normalized PE Ratio | 15.75 |